Recently, our unit has used a polyclonal antilymphocyte agent frequently to treat steroid-resistant rejection or induce immunosuppression. A system of monitoring has been developed to govern the use of this powerful agent. This technique has allowed reduction in the total dose of ATG with no loss of efficacy but a decrease in the rate of serious viral infection. Powerful polyclonal agents remain an important element of immunosuppression provided that the dose of the agent is tailored to the individual response.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
polyclonal antilymphocyte
8
sensitive monitoring
4
monitoring polyclonal
4
antilymphocyte agents
4
agents renal
4
renal transplantation
4
transplantation unit
4
unit polyclonal
4
antilymphocyte agent
4
agent frequently
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!